Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Introduction</h3><p>Depression, the most prevalent mood disorder, has high comorbidity with cerebrovascular disease and cognitive decline. However, there is little understanding of the cellular mechanisms involved in depression and its comorbid cerebrovascular damage and cognition impairment. Here, we tested the prediction that the chronic unpredictable mild stress (CUMS) mouse model would manifest in disturbed glymphatic function and that dietary supplementation with polyunsaturated fatty acids (PUFA) could ameliorate these deficits while alleviating the depression-associated cognitive decline.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>To test the treatment effects of PUFA or Es on behaviours, we applied the tail suspension, open field, and sucrose preference tests to assess depressive symptoms, and applied the Morris water maze test to assess cognition in groups of control, chronic unpredictable mild stress (CUMS), PUFA, and escitalopram (Es) treatment. We measured the extracellular concentrations of dopamine (DA), 5-hydroxytryptamine (5-HT) and noradrenaline (NA) in microdialysates from prefrontal cortex (PFC) by liquid chromatography mass spectrometry. Glia cells and inflammatory factors were analysed with fluorescent immunochemistry and western blot, respectively. We tested brain vasomotor function with two-photon and laser speckle imaging in vivo, and measured glymphatic system function by two-photon imaging in vivo and fluorescence tracer imaging ex vivo, using awake and anesthetized mice. Besides, we monitored cortical spreading depression by laser speckle imaging system. AQP4 depolarization is analysed by fluorescent immunochemistry and western blot.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We confirmed that CUMS elicited depression-like and amnestic symptoms, accompanied by decreased monoamines neurotransmitter concentration in PFC and upregulated neuroinflammation markers. Moreover, CUMS mice showed reduced arterial pulsation and compliance in brain, and exhibited depolarized expression of AQP4, thus indicating glymphatic dysfunction both in awake and anesthetized states. PUFA supplementation rescued depression-like behaviours of CUMS mice, reduced neuroinflammation and cerebrovascular dysfunction, ultimately improved cognitive performance, all of which accompanied by restoring glymphatic system function. In contrast, Es treatment alleviated only the depression-like behavioural symptoms, while showing no effects on glymphatic function and depression-incident cognitive deficits.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>The CUMS depression model entails suppression of the glymphatic system. PUFA supplementation rescued most behavioural signs of depression and the associated cognitive dysfunction by restoring the underlying glymphatic system disruption and protecting cerebral vascular function.</p>

Krill oil treatment ameliorates lipid metabolism imbalance in chronic unpredicted mild stress-induced depression-like behavior in mice

Fish Oil Supplementation Alleviates Depressant-Like Behaviors and Modulates Lipid Profiles in Rats Exposed to Chronic Unpredictable Mild Stress

Polyunsaturated fatty acid supplement alleviates depression-incident cognitive dysfunction by protecting the cerebrovascular and glymphatic systems

Alleviation of Antarctic Krill Oil on Dextran Sulfate Sodium Exposure Induced Chronic Ulcerative Colitis and Depressive-Like Behavior

Quercetin modulates the liver metabolic profile in a chronic unpredictable mild stress rat model based on metabolomics technology

Anti-depressant Effect of Zhi-zi-chi Decoction on CUMS Mice and Elucidation of Its Signaling Pathway

Quantitative Proteomics Analysis of the Liver Reveals Immune Regulation and Lipid Metabolism Dysregulation in a Mouse Model of Depression.

EPA is More Effective than DHA to Improve Depression-Like Behavior, Glia Cell Dysfunction and Hippcampal Apoptosis Signaling in a Chronic Stress-Induced Rat Model of Depression

Hippocampal mRNA expression profiling in mice exposed to chronic unpredictable mild stress

Resveratrol Exerts Antidepressant Properties in the Chronic Unpredictable Mild Stress Model Through the Regulation of Oxidative Stress and Mtor Pathway in the Rat Hippocampus and Prefrontal Cortex.

Integrated 16S rRNA sequencing and metabolomics analysis to investigate the antidepressant role of Yang-Xin-Jie-Yu decoction on microbe-gut-metabolite in chronic unpredictable mild stress-induced depression rat model

[Behaviors and Brain Glucose Metabolism in a Rat Hyperlipidemia Model with Depression from Chronic Unpredictable Mild Stress].

Du-moxibustion ameliorates depression-like behavior and neuroinflammation in chronic unpredictable mild stress-induced mice

Dihydroartemisinin protects mice from CUMS-induced depression-like behaviors and regulates gut microbes

Metabolomics Analysis of the Prefrontal Cortex in a Rat Chronic Unpredictable Mild Stress Model of Depression

CUMS induces depressive-like behaviors and cognition impairment by activating the ERS-NLRP3 signaling pathway in mice

Quercetin attenuates brain apoptosis in mice with chronic unpredictable mild stress-induced depression

Antidepressant Drugs Correct the Imbalance Between Probdnf/p75ntr/sortilin and Mature BDNF/TrkB in the Brain of Mice with Chronic Stress

Hypothalamic Proteomic Analysis Reveals Dysregulation of Glutamate Balance and Energy Metabolism in a Mouse Model of Chronic Mild Stress-Induced Depression

Inhalation of Curcumae Rhizoma Volatile Oil Attenuates Depression-Like Behaviours Via Activating the Nrf2 Pathway to Alleviate Oxidative Stress and Improve Mitochondrial Dysfunction.

Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system